Merck Invests €13 Million in Bengaluru Manufacturing Facility

Merck, a German science and tech company, has invested approximately EUR 13 million in its Jigani manufacturing facility in Bengaluru. The expansion adds biological buffer manufacturing to the site's existing chemistry capabilities.

The Manufacturing Hub will supply critical materials for research, diagnostics, biotechnology, and biopharmaceutical production in India and the Asia-Pacific region.

Operational since 2003, the 10-acre facility has various capabilities, including specialty and fine chemicals, custom synthesis, and catalogue product manufacturing. The site also houses a Microbiology Application and Training Lab, a Stable Isotopes Manufacturing Plant developed in collaboration with the Heavy Water Board under the Department of Atomic Energy, and a 7,200-square-metre temperature-controlled distribution centre.

'India is emerging as an increasingly important hub for life science innovation and manufacturing,' said Dhananjay Singh, Managing Director, Life Science business of Merck, India. 'Merck is investing about €13 million in its Jigani site to strengthen regional manufacturing and expand biology and chemistry capabilities across India and the Asia-Pacific region.'